By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Avalanche Biotechnologies 

1035 O'Brien Drive
Suite B
Menlo Park  California  94025  U.S.A.
Phone: 650-735-1324 Fax: 650-362-1908


SEARCH JOBS


Industry
Biotechnology


Collaborations

Regeneron 





Company News
Avalanche Biotech (AAVL) Goes Back to Drawing Board, Performs More Preclinical Studies on Eye Drug 8/14/2015 6:32:19 AM
Avalanche Biotech (AAVL) Awarded As Technology Pioneer By World Economic Forum 8/5/2015 7:26:47 AM
Avalanche Biotech (AAVL) CEO Resigns Amidst Clinical Data Questions and Stock Plummeting 7/24/2015 7:31:14 AM
Avalanche Biotech (AAVL) Announces Positive Top-Line Phase IIa Results For AVA-101 In Wet Age-Related Macular Degeneration 6/16/2015 8:19:38 AM
Analysts Question Avalanche Biotech (AAVL) Clinical Data, Could Jeopardize Regeneron (REGN) Deal 6/16/2015 6:31:28 AM
Avalanche Biotechnologies (AAVL) Presents Three Posters At American Society Of Gene & Cell Therapy (ASGCT) Annual Meeting 5/15/2015 10:19:17 AM
Avalanche Biotechnologies (AAVL) Reports First Quarter 2015 Financial Results 5/13/2015 10:54:00 AM
Avalanche Biotechnologies (AAVL) To Present At Upcoming Scientific Meetings 4/28/2015 6:47:00 AM
Avalanche Biotechnologies (AAVL) And The University of Washington Enter Into Exclusive License Agreement To Develop Gene Therapy Medicines To Treat Color Blindness 3/25/2015 7:36:45 AM
Avalanche Biotechnologies (AAVL) To Host Analyst And Investor Day On March 25, 2015 3/18/2015 7:51:08 AM
123
//-->